Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients.

Liu, Kaiyan; Stern, Sydney; Heil, Emily L; Li, Linhao; Khairi, Rula; Heyward, Scott; Wang, Hongbing

Liu, Kaiyan; Stern, Sydney; Heil, Emily L; Li, Linhao; Khairi, Rula; Heyward, Scott; Wang, Hongbing.

Affiliation

Liu K; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Stern S; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Heil EL; Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Li L; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Khairi R; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Heyward S; BioIVT, 1450 S Rolling Rd, Halethorpe, Maryland, USA.
Wang H; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.

Hepatol Commun ; 7(3): e0034, 2023 03 01.

Article de En | MEDLINE | ID: mdl-36809346

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lésions hépatiques dues aux substances / COVID-19 Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Hepatol Commun Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google